STOCK TITAN
  1. Home
  2. ONPPF

Oncopeptides Stock Price, News & Analysis

ONPPF OTC

Company Description

Oncopeptides (OTC: ONPPF) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

ONPPF stock has declined 68.8% over the past year.

This page provides a comprehensive overview of ONPPF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-68.82%
Performance 1 year
$0.0
Market Cap
211.3M
Shares outstanding

Oncopeptides (ONPPF) stock. Over the past 12 months, the stock has lost 68.8%.

Latest News

View All
0.00%

Number of shares and votes in Oncopeptides

0.00%

FDA announces an Oncologic Drugs Advisory Committee meeting to discuss benefit/risk profile of Oncopeptides' Pepaxto

fda approval
0.00%

Oncopeptides rescinds voluntary withdrawal of Pepaxto in the US - no intent to market in the US at this time

0.00%

Oncopeptides presents phase 3 OCEAN study results at the IMW meeting

clinical trial
0.00%

Bulletin from the Annual General Meeting in Oncopeptides AB (publ)

0.00%

Oncopeptides completes patient enrollment in phase 2 PORT study

clinical trial

Oncopeptides has 10 recent news articles. Key topics include fda approval, clinical trial. View all ONPPF news →

SEC Filings

View All

No SEC filings available for ONPPF.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ONPPF Company Profile & Sector Positioning

Oncopeptides (ONPPF) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC.